$AMGN · Amgen Inc.
Amgen Inc. filed a Form 3 initial statement of beneficial ownership for Arleen Paulino, who became an executive vice president of operations effective November 16, 2026. The filing discloses her holdings in Amgen securities as of that date.
Ms. Paulino directly owns 4,455 shares of common stock, which includes 2,181 restricted stock units and 66 dividend equivalents tied to unvested restricted stock units. She also indirectly holds 2,039.9774 shares through the company’s 401(k) plan. In addition, the filing reports eight non-qualified stock option grants covering a total of 81,265 shares, with exercise prices ranging from $230.15 to $329.59 per share. Several of these option grants are fully vested and exercisable, while others vest in future annual installments beginning in 2027.